NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

RecruitingPhase 3

Sponsor: Universitätsklinikum Hamburg-Eppendorf

Conditions: Acute Ischemic Stroke, Atrial Fibrillation

Interventions: Medical or interventional therapy for rhythm control in atrial fibrillation (antiarrhythmic drugs, ablation, electric cardio version), Usual care for atrial fibrillation

Countries: Germany

This study will determine whether early, comprehensive, rhythm control therapy prevents adverse cardiovascular outcome in patients with acute ischemic stroke and atrial fibrillation compared to usual care.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Acute ischemic stroke in the previous four weeks, diagnosed by imaging (CT or MRI) or clinical diagnosis
* Possibility to start the trial treatment within 4 weeks after stroke, and as soon as clinically justifiable
* AF first detected ≤1 year prior to randomization
* Informed consent

Exclusion Criteria:

* End-stage cancer or life-expectancy \< 12 months due to other advanced co-morbid illness
* Prior AF ablation or surgical therapy of AF
* Patients not suitable for rhythm control of AF due to cardiac conditions

Locations (1)

Hamburg, Germany